Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-26

FDA Approved: RIVAROXABAN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' generic rivaroxaban (RIVAROXABAN) under an Original Application, enabling a generic version of the anticoagulant. It covers in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)